Dr. Levi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1431 N. Western Ave.
Ste. 510
Chicago, IL 60622Phone+1 773-878-6233Fax+1 773-848-6233
Summary
- Dr. Roberto Levi is an orthopedic surgeon in Chicago, IL and is affiliated with multiple hospitals in the area, including Louis A. Weiss Memorial Hospital, Swedish Covenant Hospital, AMITA Health Resurrection Medical Center - Chicago, Advocate Illinois Masonic Medical Center, Norwegian American Hospital, and AMITA Health Saints Mary & Elizabeth Medical Center Chicago. He received his medical degree from University of Buenos Aires and has been in practice 50 years. He is experienced in hand and wrist surgery and shoulder and elbow surgery.
Education & Training
- Michael Reese Hospital and Medical CenterResidency, Orthopaedic Surgery, 1974 - 1977
- Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 1973 - 1974
- University of Buenos AiresClass of 1967
Certifications & Licensure
- IL State Medical License 1975 - 2026
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Publications & Presentations
PubMed
- 9 citationsA Retinoic Acid Receptor β2 Agonist Improves Cardiac Function in a Heart Failure Model.Xiao-Han Tang, Jessica Gambardella, Stanislovas S. Jankauskas, Xujun Wang, Gaetano Santulli
The Journal of Pharmacology and Experimental Therapeutics. 2021-08-13 - 8 citationsA RETINOIC ACID β2-RECEPTOR AGONIST EXERTS CARDIOPROTECTIVE EFFECTSAlice Marino, Takuya Sakamoto, Xiao-Han Tang, Lorraine J. Gudas, Roberto Levi
The Journal of Pharmacology and Experimental Therapeutics. 2018-01-01 - 27 citationsS1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2Alice Marino, Takuya Sakamoto, Pablo A. Robador, Kengo Tomita, Roberto Levi
The Journal of Pharmacology and Experimental Therapeutics. 2017-05-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: